Skip to main content
. 2023 Nov 1;4:37. doi: 10.1186/s43556-023-00147-x

Table 1.

Correlations between SCARNA12 expression and clinicopathological parameters of CRC patients

SCARNA12 Expression
characteristics case Low High χ2 P
Sex 0.013 0.910
 Female 157 78 79
 Male 157 79 78
Age(year) 0.116 0.733
  ≤ 70 175 89 86
  > 70 139 68 71
TNM stage(AJCC) 0.052 0.820
 Stage I/II 178 88 90
 Stage III/IV 136 69 67
Pathological T category 0.183 0.669
 T1/T2 61 32 29
 T3/T4 253 125 128
Lymph node metastasis 0.117 0.732
 Negative 181 89 92
 Positive 133 68 65
Distant metastasis 0.211 0.646
 Negative 263 133 130
 Positive 51 24 27
Lymphatic invasion 3.007 0.083
 Negative 191 103 88
 Positive 123 54 69
Venous invasion 0.017 0.897
 Negative 233 117 116
 Positive 81 40 41
History of colon polyps 11.504  < 0.001
 Negative 214 121 93
 Positive 100 36 64

Cutoff threshold of SCARNA12 expression is median value in all patients in this cohort

Abbreviations: AJCC American Joint Committee on cancer